Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification

Journal of Substance Abuse Treatment

Volumn 59, Issue , 2015, Pages 99-103

  Stein, Michael D ^a,b   Anderson, Bradley J ^a   Bailey, Genie L ^b,c  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c Stanley Street Treatment and Resources Inc   (United States)

Author keywords

Aftercare; Detoxification; Opioid; Residential treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE;

ADULT; AFTERCARE; ARTICLE; DETOXIFICATION; FEMALE; HALFWAY HOUSE; HOMELESSNESS; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; OUTPATIENT CARE; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRIORITY JOURNAL; RESIDENTIAL CARE; CLINICAL TRIAL (TOPIC); HOMELESS PERSON; MASSACHUSETTS; OPIOID-RELATED DISORDERS; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AFTERCARE; CLINICAL TRIALS AS TOPIC; FEMALE; HOMELESS PERSONS; HUMANS; MALE; MASSACHUSETTS; OPIOID-RELATED DISORDERS; PATIENT PREFERENCE; RESIDENTIAL TREATMENT; SEX FACTORS;

EID: 84945462358     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.07.002     Document Type: Article

References (62)

1. Amato L., Davoli M., Ferri M., Gowing L., Perucci C.A. Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews. Drug and Alcohol Dependence 2004, 73(3):219-226. 10.1016/j.drugalcdep.2003.11.002.
2. Amato L., Davoli M., Minozzi S., Ferroni E., Ali R., Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews 2013, 2:CD003409. 10.1002/14651858.CD003409.pub4.
3. Amato L., Minozzi S., Davoli M., Vecchi S. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database of Systematic Reviews 2011, 10:CD004147. 10.1002/14651858.CD004147.pub4.
4. Bailey G.L., Herman D.S., Stein M.D. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification. Journal of Substance Abuse Treatment 2013, 45(3):302-305. 10.1016/j.jsat.2013.04.002.
5. Bart G. Maintenance medication for opiate addiction: The foundation of recovery. Journal of Addictive Diseases 2012, 31(3):207-225. 10.1080/10550887.2012.694598.
6. Battersby M., Von Korff M., Schaefer J., Davis C., Ludman E., Greene S.M., et al. Twelve evidence-based principles for implementing self-management support in primary care. Joint Commission Journal on Quality and Patient Safety 2010, 36(12):561-570.
7. Broers B., Giner F., Dumont P., Mino A. Inpatient opiate detoxification in Geneva: Follow-up at 1 and 6months. Drug and Alcohol Dependence 2000, 58(1-2):85-92.
8. Carrier E., McNeely J., Lobach I., Tay S., Gourevitch M.N., Raven M.C. Factors associated with frequent utilization of crisis substance use detoxification services. Journal of Addictive Diseases 2011, 30(2):116-122. ([pii] 936254277). 10.1080/10550887.2011.554776.
9. Chutuape M.A., Jasinski D.R., Fingerhood M.I., Stitzer M.L. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. American Journal of Drug and Alcohol Abuse 2001, 27(1):19-44.
10. Coleman K., Austin B.T., Brach C., Wagner E.H. Evidence on the chronic care model in the new millennium. Health affairs (Project Hope) 2009, 28(1):75-85. 10.1377/hlthaff.28.1.75.
11. Collins E.D., Horton T., Reinke K., Amass L., Nunes E.V. Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation. Journal of Substance Abuse Treatment 2007, 32(2):167-175. 10.1016/j.jsat.2006.03.018.
12. Conner B.T., Hampton A.S., Hunter J., Urada D. Treating opioid use under California's Proposition 36: Differential outcomes by treatment modality. Journal of Psychoactive Drugs 2011, (Suppl. 7):77-83.
13. Cunningham C.O., Giovanniello A., Li X., Kunins H.V., Roose R.J., Sohler N.L. A comparison of buprenorphine induction strategies: Patient-centered home-based inductions versus standard-of-care office-based inductions. Journal of Substance Abuse Treatment 2011, 40(4):349-356. 10.1016/j.jsat.2010.12.002.
14. Degenhardt L., Bucello C., Mathers B., Briegleb C., Ali H., Hickman M., et al. Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies. Addiction 2011, 106(1):32-51. 10.1111/j.1360-0443.2010.03140.x.
15. Degenhardt L., Whiteford H.A., Ferrari A.J., Baxter A.J., Charlson F.J., Hall W.D., et al. Global burden of disease attributable to illicit drug use and dependence: Findings from the Global Burden of Disease Study 2010. Lancet 2013, 382(9904):1564-1574. 10.1016/S0140-6736(13)61530-5.
16. Drummond D.C. Treatment services for alcohol use disorders. Oxford Textbooks of Psychiatry 2009, Oxford University Press, Oxford. 2nd ed. M. Gelder, J. Lopez-Ibor, N. Andreason, J. Geddes (Eds.).
17. Franklin G.M., Mai J., Turner J., Sullivan M., Wickizer T., Fulton-Kehoe D. Bending the prescription opioid dosing and mortality curves: Impact of the Washington State opioid dosing guideline. American Journal of Industrial Medicine 2012, 55(4):325-331. 10.1002/ajim.21998.
18. French M.T., Salome H.J., Krupski A., McKay J.R., Donovan D.M., McLellan A.T., et al. Benefit-cost analysis of residential and outpatient addiction treatment in the State of Washington. Evaluation Review 2000, 24(6):609-634.
19. Ghodse H. Ghodse's drugs and addictive behaviour: A guide to treatment 2010, Cambridge University Press, Cambridge (UK). 4th ed.
20. Gossop M. The treatment mapping survey; A descriptive study of drug and alcohol treatment responses in 23 countries. Drug and Alcohol Dependence 1995, 39(1):7-14.
21. Gossop M., Marsden J., Stewart D., Rolfe A. Treatment retention and 1year outcomes for residential programmes in England. Drug and Alcohol Dependence 1999, 57(2):89-98.
22. Haley S.J., Dugosh K.L., Lynch K.G. Performance contracting to engage detoxification-only patients into continued rehabilitation. Journal of Substance Abuse Treatment 2011, 40(2):123-131. 10.1016/j.jsat.2010.09.001.
23. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 1979, 6:65-70.
24. Hubbard R.L., Craddock S.G., Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). Journal of Substance Abuse Treatment 2003, 25(3):125-134.
25. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug abuse treatment: A national study of effectiveness 1989, The University of North Carolina Press, Chapel Hill, NC.
26. Kertesz S.G., Crouch K., Milby J.B., Cusimano R.E., Schumacher J.E. Housing first for homeless persons with active addiction: Are we overreaching?. Milbank Quarterly 2009, 87(2):495-534. 10.1111/j.1468-0009.2009.00565.x.
27. Krupitsky E., Nunes E.V., Ling W., Illeperuma A., Gastfriend D.R., Silverman B.L. Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial. Lancet 2011, 377(9776):1506-1513. 10.1016/S0140-6736(11)60358-9.
28. Lundgren L.M., Sullivan L., Amodeo M. How do treatment repeaters use the drug treatment system? An analysis of injection drug users in Massachusetts. Journal of Substance Abuse Treatment 2006, 30(2):121-128. 10.1016/j.jsat.2005.10.007.
29. Luty J. Treatment preferences of opiate-dependent patients. Psychiatric Bulletin 2004, 28(2):47-50. 10.1192/pb.28.2.47.
30. Mark T.L., Dilonardo J.D., Chalk M., Coffey R.M. Trends in inpatient detoxification services, 1992-1997. Journal of Substance Abuse Treatment 2002, 23(4):253-260. (doi: S0740547202002714 [pii]).
31. Mark T.L., Dilonardo J.D., Chalk M., Coffey R. Factors associated with the receipt of treatment following detoxification. Journal of Substance Abuse Treatment 2003, 24(4):299-304. (doi: S0740547203000394 [pii]).
32. Mattick R.P., Breen C., Kimber J., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2014, 2:CD002207. 10.1002/14651858.CD002207.pub4.
33. Mattick R.P., Hall W. Are detoxification programmes effective?. Lancet 1996, 347(8994):97-100.
34. McCarty D., Fuller B., Kaskutas L.A., Wendt W.W., Nunes E.V., Miller M., et al. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug and Alcohol Dependence 2008, 92(1-3):200-207. 10.1016/j.drugalcdep.2007.08.004.
35. McKay J.R., Rutherford M.J., Alterman A.I., Cacciola J.S., Kaplan M.R. An examination of the cocaine relapse process. Drug and Alcohol Dependence 1995, 38(1):35-43.
36. Mee-Lee D., Shulman G. The ASAM placement criteria and matching patients to treatment. Principles of Addiction Medicine 2009, 387-399. Lippincott William & Wilkins, Philadelphia, PA. R.K. Ries, S. Miller, D.A. Fiellin, R. Saitz (Eds.).
37. National Collaborating Centre for Mental Health Drug Misuse: Opioid Detoxification, NICE Guideline 2008, National Institute for Health & Clinical Excellence, Leicester (UK).
38. National Institute on Alcohol Abuse and Alcoholism Helping Patients Who Drink Too Much: A Clinician's Guide 2005, U.S. Department of Health and Human Services.
39. Orford J. Addiction as excessive appetite. Addiction 2001, 96(1):15-31. 10.1080/09652140020016932.
40. Reifler L.M., Droz D., Bailey J.E., Schnoll S.H., Fant R., Dart R.C., et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse?. Pain Medicine 2012, 13(3):434-442. 10.1111/j.1526-4637.2012.01327.x.
41. Ridge G., Gossop M., Lintzeris N., Witton J., Strang J. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence. Journal of Substance Abuse Treatment 2009, 37(1):95-100. 10.1016/j.jsat.2008.09.007.
42. Rosen C.S., Drescher K.D., Moos R.H., Finney J.W., Murphy R.T., Gusman F. Six- and ten-item indexes of psychological distress based on the Symptom Checklist-90. Assessment 2000, 7(2):103-111.
43. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11(4):294-307. 10.1037/0893-164X.11.4.294.
44. Simpson D.D., Sells S.B. Effectiveness of treatment for drug abuse: An overview of the DARP research program. Advances in Alcohol & Substance Abuse 1982, 2(1):7-29. 10.1300/J251v02n01_02.
45. Smyth B.P., Barry J., Keenan E., Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Irish Medical Journal 2010, 103(6):176-179.
46. Sohler N.L., Li X., Kunins H.V., Sacajiu G., Giovanniello A., Whitley S., et al. Home- versus office-based buprenorphine inductions for opioid-dependent patients. Journal of Substance Abuse Treatment 2010, 38(2):153-159. 10.1016/j.jsat.2009.08.001.
47. Specka M., Buchholz A., Kuhlmann T., Rist F., Scherbaum N. Prediction of the outcome of inpatient opiate detoxification treatment: Results from a multicenter study. European Addiction Research 2011, 17(4):178-184. 10.1159/000324873.
48. Stein M.D., Anderson B.J., Thurmond P., Bailey G.L. Comparing the life concerns of prescription opioid and heroin users. Journal of Substance Abuse Treatment 2015, 48(1):43-48. 10.1016/j.jsat.2014.07.001.
49. Substance Abuse and Mental Health Services Administration The DASIS Report: Admissions for detoxification, 2001 2004, Office of Applied Studies, Rockville, MD.
50. Substance Abuse and Mental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of national findings 2013, Substance Abuse and Mental Health Services Administration, Rockville, MD.
51. Teesson M., Havard A., Ross J., Darke S. Outcomes after detoxification for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 2006, 25(3):241-247. 10.1080/09595230600657733.
52. Teesson M., Ross J., Darke S., Lynskey M., Ali R., Ritter A., et al. One year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence 2006, 83(2):174-180. 10.1016/j.drugalcdep.2005.11.009.
53. Tiet Q.Q., Ilgen M.A., Byrnes H.F., Harris A.H., Finney J.W. Treatment setting and baseline substance use severity interact to predict patients' outcomes. Addiction 2007, 102(3):432-440. 10.1111/j.1360-0443.2006.01717.x.
54. Tuten M., Defulio A., Jones H.E., Stitzer M. Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction 2012, 107(5):973-982. 10.1111/j.1360-0443.2011.03750.x.
55. Tuten M., Jones H.E., Lertch E.W., Stitzer M.L. Aftercare plans of inpatients undergoing detoxification. American Journal of Drug and Alcohol Abuse 2007, 33(4):547-555. 10.1080/00952990701407454.
56. U.S.Census Bureau State and county quickfacts Accessed April, 2015. http://quickfacts.census.gov/qfd/states/25/2523000.html.
57. U.S.Department of Health and Human Services Detoxification from alcohol and other drugs: Treatment improvement protocol (TIP) series 19. (DHHS Publication No. (SMA) 95-3046) 1995, Substance Abuse and Mental Health Services Administration, Rockville, MD.
58. Volkow N.D., Frieden T.R., Hyde P.S., Cha S.S. Medication-assisted therapies--tackling the opioid-overdose epidemic. New England Journal of Medicine 2014, 370(22):2063-2066. 10.1056/NEJMp1402780.
59. Wang G.J., Volkow N.D., Fowler J.S., Cervany P., Hitzemann R.J., Pappas N.R., et al. Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sciences 1999, 64(9):775-784.
60. Watkins K., Pincus H.A., Tanielian T.L., Lloyd J. Using the chronic care model to improve treatment of alcohol use disorders in primary care settings. Journal of Studies on Alcohol 2003, 64(2):209-218.
61. World Health Organization Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence 2009, World Health Organization, Geneva, Switzerland.
62. Wu L.T., Ling W., Burchett B., Blazer D.G., Shostak J., Woody G.E. Gender and racial/ethnic differences in addiction severity, HIV risk, and quality of life among adults in opioid detoxification: Results from the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse and Rehabilitation 2010, 2010(1):13-22. 10.2147/SAR.S15151.